Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M707941200 on April 1, 2008

J. Biol. Chem., Vol. 283, Issue 22, 15078-15088, May 30, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/22/15078    most recent
M707941200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Audet, N.
Right arrow Articles by Pineyro, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Audet, N.
Right arrow Articles by Pineyro, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Bioluminescence Resonance Energy Transfer Assays Reveal Ligand-specific Conformational Changes within Preformed Signaling Complexes Containing {delta}-Opioid Receptors and Heterotrimeric G Proteins*Formula

Nicolas Audet{ddagger}§, Céline Galés||, Élodie Archer-Lahlou{ddagger}§1, Marc Vallières{ddagger}, Peter W. Schiller§**, Michel Bouvier{ddagger}{ddagger}2, and Graciela Pineyro{ddagger}§§§3

From the {ddagger}Centre de Recherche Fernand-Seguin, Hôpital Louis-H. Lafontaine, Montréal, Quebec H1N 3V2, Canada, the §Département de Pharmacologie, {ddagger}{ddagger}Département de Biochimie, and §§Département de Psychiatrie, Faculté de Médecine, Universitéde Montréal, Montréal, Quebec H3C 3J7, Canada, Groupe de Recherche Universitaire sur le Médicament, Montréal, Quebec H3C 3J7, Canada, ||INSERM Unité 858, Équipe 8, Institut Louis Bugnard, Toulouse 31432, France, and **Laboratory of Chemical Biology and Peptide Research, Institut de Recherches Cliniques de Montréal, Montréal, Quebec 2W 1R7, Canada

Heptahelical receptors communicate extracellular information to the cytosolic compartment by binding an extensive variety of ligands. They do so through conformational changes that propagate to intracellular signaling partners as the receptor switches from a resting to an active conformation. This active state has been classically considered unique and responsible for regulation of all signaling pathways controlled by a receptor. However, recent functional studies have challenged this notion and called for a paradigm where receptors would exist in more than one signaling conformation. This study used bioluminescence resonance energy transfer assays in combination with ligands of different functional profiles to provide in vivo physical evidence of conformational diversity of {delta}-opioid receptors (DORs). DORs and {alpha}i1β1{gamma}2 G protein subunits were tagged with Luc or green fluorescent protein to produce bioluminescence resonance energy transfer pairs that allowed monitoring DOR-G protein interactions from different vantage points. Results showed that DORs and heterotrimeric G proteins formed a constitutive complex that underwent structural reorganization upon ligand binding. Conformational rearrangements could not be explained by a two-state model, supporting the idea that DORs adopt ligand-specific conformations. In addition, conformational diversity encoded by the receptor was conveyed to the interaction among heterotrimeric subunits. The existence of multiple active receptor states has implications for the way we conceive specificity of signal transduction.


Received for publication, September 21, 2007 , and in revised form, February 26, 2008.

* This work was supported by a grant from the National Sciences and Engineering Research Council of Canada and Grant MOP7 9432 from the Canadian Institutes of Health Research (to G. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains Fig. 1.

1 Recipient of a Fond de Recherche en Santé du Québec (FRSQ) postdoctoral fellowship.

2 Holder of a Canada Research Chair in molecular pharmacology and signal transduction.

3 Recipient of an FRSQ young investigator award. To whom correspondence should be addressed: Dépt. de Psychiatrie, Université de Montréal, 7331 Rue Hochelaga, Montréal, Quebec H1N 3V2, Canada. Tel.: 514-251-4015; Fax: 514-251-2617; E-mail: graciela.pineyro.filpo{at}umontreal.ca.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
A. Levoye, K. Balabanian, F. Baleux, F. Bachelerie, and B. Lagane
CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling
Blood, June 11, 2009; 113(24): 6085 - 6093.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement